approval · primary record
DURVALUMAB
FDA · BLA · 2026-08-31
| Agency | FDA |
|---|---|
| Submission type | BLA |
| Action date | 2026-08-31 |
| Brand | IMFINZI |
| Sponsor | ASTRAZENECA UK LTD |
| Route | INJECTION |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-28T10:38:32.353Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: FDA:DURVALUMAB:2026-08-31
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Durvalumab · trial
- Durvalumab · trial
- durvalumab · trial
- Durvalumab · trial
- Durvalumab · trial
- Durvalumab · compound